Bypass grafts: the state of the art.
The treatment options for infra-renal arteriosclerotic occlusive (ASO) vascular disease have never been more varied. The history of open revascularization procedures now exceeds 60 years. This represents three generations of vascular surgeons, the most recent of whom have witnessed more than 30 years of endovascular surgery development and dissemination. Both open and endovascular treatments should be considered mature; moreover, we are improving our understanding of the strategies and tactics that lead to the clinical application of one approach instead of the other. There are other important factors in the choice of a treatment modality to be used for a specific patient. Prime among these is evolving patterns of occlusive disease and the increasing severity of arterial calcification.